These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 25660064)
21. The role of the cytoskeleton in cellular adhesion molecule expression in tumor necrosis factor-stimulated endothelial cells. VandenBerg E; Reid MD; Edwards JD; Davis HW J Cell Biochem; 2004 Apr; 91(5):926-37. PubMed ID: 15034928 [TBL] [Abstract][Full Text] [Related]
22. The Rho kinase inhibitor fasudil augments the number of functional endothelial progenitor cells in ex vivo cultures. O E; Ahn HY; Kim HK; You JC; Shin JC; Joe YA Int J Mol Med; 2011 Sep; 28(3):357-63. PubMed ID: 21567077 [TBL] [Abstract][Full Text] [Related]
23. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization. Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352 [TBL] [Abstract][Full Text] [Related]
24. TGFbeta1-induced aortic endothelial morphogenesis requires signaling by small GTPases Rac1 and RhoA. Varon C; Basoni C; Reuzeau E; Moreau V; Kramer IJ; Génot E Exp Cell Res; 2006 Nov; 312(18):3604-19. PubMed ID: 16978608 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of Rho kinases increases directional motility of microvascular endothelial cells. Breyer J; Samarin J; Rehm M; Lautscham L; Fabry B; Goppelt-Struebe M Biochem Pharmacol; 2012 Mar; 83(5):616-26. PubMed ID: 22192821 [TBL] [Abstract][Full Text] [Related]
27. Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells. Wojciak-Stothard B; Tsang LY; Haworth SG Am J Physiol Lung Cell Mol Physiol; 2005 Apr; 288(4):L749-60. PubMed ID: 15591411 [TBL] [Abstract][Full Text] [Related]
28. The effect of Rho-associated kinase inhibition on the ocular penetration of timolol maleate. Arnold JJ; Hansen MS; Gorman GS; Inoue T; Rao V; Spellen S; Hunsinger RN; Chapleau CA; Pozzo-Miller L; Stamer WD; Challa P Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1118-26. PubMed ID: 23307957 [TBL] [Abstract][Full Text] [Related]
29. Signaling through Rho GTPase pathway as viable drug target. Lu Q; Longo FM; Zhou H; Massa SM; Chen YH Curr Med Chem; 2009; 16(11):1355-65. PubMed ID: 19355891 [TBL] [Abstract][Full Text] [Related]
30. Roles of lysophosphatidic acid and the Rho-associated kinase pathway in the migration of dental pulp cells. Cheng R; Cheng L; Shao MY; Yang H; Wang FM; Hu T; Zhou XD Exp Cell Res; 2010 Apr; 316(6):1019-27. PubMed ID: 20064505 [TBL] [Abstract][Full Text] [Related]
31. MIP-2 causes differential activation of RhoA in mouse aortic versus pulmonary artery endothelial cells. Moldobaeva A; Baek A; Wagner EM Microvasc Res; 2008 Jan; 75(1):53-8. PubMed ID: 17662312 [TBL] [Abstract][Full Text] [Related]
33. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Butcher JT; Penrod AM; García AJ; Nerem RM Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1429-34. PubMed ID: 15117733 [TBL] [Abstract][Full Text] [Related]
34. RhoA/ROCK-mediated switching between Cdc42- and Rac1-dependent protrusion in MTLn3 carcinoma cells. El-Sibai M; Pertz O; Pang H; Yip SC; Lorenz M; Symons M; Condeelis JS; Hahn KM; Backer JM Exp Cell Res; 2008 Apr; 314(7):1540-52. PubMed ID: 18316075 [TBL] [Abstract][Full Text] [Related]
35. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway. Sun X; Sun Y; Jiang P; Qi G; Chen X Biomed Pharmacother; 2020 Apr; 124():109822. PubMed ID: 31958767 [TBL] [Abstract][Full Text] [Related]
36. HIF-1α activation results in actin cytoskeleton reorganization and modulation of Rac-1 signaling in endothelial cells. Weidemann A; Breyer J; Rehm M; Eckardt KU; Daniel C; Cicha I; Giehl K; Goppelt-Struebe M Cell Commun Signal; 2013 Oct; 11():80. PubMed ID: 24144209 [TBL] [Abstract][Full Text] [Related]
37. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Lepley D; Paik JH; Hla T; Ferrer F Cancer Res; 2005 May; 65(9):3788-95. PubMed ID: 15867375 [TBL] [Abstract][Full Text] [Related]
38. A Rho-associated coiled-coil containing kinases (ROCK) inhibitor, Y-27632, enhances adhesion, viability and differentiation of human term placenta-derived trophoblasts in vitro. Motomura K; Okada N; Morita H; Hara M; Tamari M; Orimo K; Matsuda G; Imadome KI; Matsuda A; Nagamatsu T; Fujieda M; Sago H; Saito H; Matsumoto K PLoS One; 2017; 12(5):e0177994. PubMed ID: 28542501 [TBL] [Abstract][Full Text] [Related]
39. ROCK is involved in vasculogenic mimicry formation in hepatocellular carcinoma cell line. Zhang JG; Li XY; Wang YZ; Zhang QD; Gu SY; Wu X; Zhu GH; Li Q; Liu GL PLoS One; 2014; 9(9):e107661. PubMed ID: 25238232 [TBL] [Abstract][Full Text] [Related]
40. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation. Zohrabian VM; Forzani B; Chau Z; Murali R; Jhanwar-Uniyal M Anticancer Res; 2009 Jan; 29(1):119-23. PubMed ID: 19331140 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]